Keywords: novartis, withdraws, eu, label, extension, zometa, swiss

Novartis withdraws EU label extension for Zometa

Article | 26 November 2007

Print This

Swiss drug major Novartis has withdrawn its application to extend the marketing authorization application to include a new indication for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in